Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VIZhyal is a biotechnology company focused on developing advanced ophthalmic solutions using proprietary cross-linked hyaluronic acid technology. The company's flagship products are designed to provide long-lasting relief for dry eye syndrome and support ocular surface healing following surgical procedures such as cataracts or refractive surgery. By utilizing a unique formulation that enhances the residence time of lubricants on the eye, VIZhyal aims to improve patient outcomes and comfort compared to traditional artificial tears. Their portfolio includes CE-marked medical devices that cater to both chronic ocular conditions and post-operative care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VIZhyal.